Raia Drogasil S.A.
RADLY · OTC
9/30/2025 | 6/30/2025 | 3/31/2025 | 12/31/2024 | |
|---|---|---|---|---|
| Market Cap | $31 | $25 | $35 | $33 |
| - Cash | $0 | $1 | $0 | $1 |
| + Debt | $8 | $8 | $8 | $8 |
| Enterprise Value | $39 | $32 | $42 | $40 |
| Revenue | $11 | $11 | $10 | $10 |
| % Growth | 4% | 7.8% | -0.4% | – |
| Gross Profit | $3 | $3 | $3 | $3 |
| % Margin | 24.9% | 29.6% | 28.7% | 29.6% |
| EBITDA | $1 | $1 | $1 | $0 |
| % Margin | 11.8% | 10.9% | 9.1% | 0.1% |
| Net Income | $0 | $0 | $0 | $0 |
| % Margin | 4% | 3.5% | 1.6% | 3.5% |
| EPS Diluted | 0.27 | 0.23 | 0.099 | 0.21 |
| % Growth | 17.4% | 132.1% | -52.8% | – |
| Operating Cash Flow | $1 | $0 | $1 | $0 |
| Capital Expenditures | -$0 | -$0 | -$0 | -$0 |
| Free Cash Flow | $1 | $0 | $0 | -$0 |